155149-67-0

Usage

Uses

Used in Pharmaceutical Industry:
4-Morpholinecarboxamide, N-[(1S)-2-[[(1S)-3-fluoro-2-oxo-1-(2-phenylethyl)propyl]amino]-2-oxo-1-(phenylmethyl)ethyl]is used as a protease inhibitor for [application reason] targeting calpain, cathepsin B and L, and Trypanosome trypanopain. Its inhibitory properties make it a potential candidate for the treatment of various diseases, including those involving abnormal protease activity.
Used in Antimalarial Applications:
In the field of antimalarial drug development, 4-Morpholinecarboxamide, N-[(1S)-2-[[(1S)-3-fluoro-2-oxo-1-(2-phenylethyl)propyl]amino]-2-oxo-1-(phenylmethyl)ethyl]is used as an inhibitor that may display anti-malarial activity. Its potential to inhibit key proteases in the Plasmodium parasite life cycle makes it a valuable compound for further research and development in the fight against malaria.
Used in Treatment of Trypanosoma cruzi Infection:
4-Morpholinecarboxamide, N-[(1S)-2-[[(1S)-3-fluoro-2-oxo-1-(2-phenylethyl)propyl]amino]-2-oxo-1-(phenylmethyl)ethyl]is used as a therapeutic agent for the treatment of Trypanosoma cruzi infection, also known as Chagas disease. Its ability to inhibit specific proteases involved in the parasite's survival and replication makes it a promising candidate for the development of new treatments for this neglected tropical disease.